<DOC>
	<DOCNO>NCT01305824</DOCNO>
	<brief_summary>The purpose study determine PRT-201 applied limit segment blood vessel ( 2 inch ) immediately surgery create arteriovenous fistula safe improve patency fistula . PRT-201 protein show help keep vessel open ( `` patent '' ) apply outside surface blood vessel ( artery vein ) AVF patient previous study .</brief_summary>
	<brief_title>A Study PRT-201 Administered Immediately After Arteriovenous Fistula Creation Patients With Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<criteria>1 . Age least 18 year . 2 . Life expectancy least 6 month . 3 . Chronic kidney disease hemodialysis , anticipated start hemodialysis within 6 month . 4 . Planned creation new radiocephalic brachiocephalic AVF . Revisions exist AVF transpose AVF acceptable . 1 . History presence arterial aneurysm . 2 . Malignancy treatment malignancy within previous 12 month exception follow cancer resect : localize basal cell cancer , squamous cell skin cancer , cancer situ . 3 . Hepatic dysfunction define bilirubin , ALT [ SGPT ] AST [ SGOT ] &gt; 2.5 time upper limit normal , decompensated cirrhosis , ascites , know esophageal gastric varix . 4 . Treatment investigational drug within previous 30 day investigational antibody therapy within 90 day prior sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>arteriovenous fistula</keyword>
	<keyword>AVF</keyword>
	<keyword>hemodialysis</keyword>
	<keyword>vascular access</keyword>
	<keyword>dialysis</keyword>
	<keyword>fistula</keyword>
	<keyword>PRT-201</keyword>
	<keyword>vonapanitase</keyword>
	<keyword>kidney</keyword>
	<keyword>renal</keyword>
</DOC>